MEGAN BANKERT: Open Payments
NPI 1700235686 · HANOVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 35 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $840
Food & beverage: $815Education: $25
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $281 |
| GENZYME CORPORATION | 4 | $131 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| BioCryst US Sales Co., LLC | 2 | $49 |
| Ionis Pharmaceuticals, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Grifols USA, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, NEFFY, ORLADEYO, TEZSPIRE, BREZTRI, TAKHZYRO.
Industry payments across PA — which companies pay providers there.
